Immune checkpoint blockade for melanoma: Should we combine or sequence ipilimumab and PD-1 antibody therapy?

Date 02 December 2015
Event Melanoma Bridge 2015
Session Combination Therapies
Topics Immunotherapy
Skin cancers
Presenter M. Postow